Vascular Access Devices - Company Evaluation Report, 2024
The Vascular Access Devices Market Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Vascular Access Devices market . This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 100 companies, of which the Top 25 Vascular Access Devices market Companies were categorized and recognized as the quadrant leaders.
A vascular access device (VAD) is a medical instrument inserted into a vein or artery to provide direct access to the bloodstream for delivering medications, fluids, or nutrients, as well as for drawing blood. Commonly used in long-term treatments like chemotherapy or dialysis, VADs are classified as central or peripheral depending on the site and duration of use. These devices are typically placed in the arm, chest, or leg and can remain in place for extended periods to support ongoing medical care.
The vascular access devices market is expected to grow from USD 5,991.2 million in 2024 to USD 9,057.2 million by 2030, at a CAGR of 7.1%. This growth is primarily driven by increased investment from key industry players and a rising prevalence of conditions that require vascular access. However, a shortage of skilled healthcare professionals may pose a challenge to market expansion.
The 360 Quadrant maps the Vascular Access Devices market companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Vascular Access Devices market quadrant. The top criteria for product footprint evaluation included Type (central venous access devices, peripheral vascular access devices, accessories, intraosseous vascular access devices), By Route of Insertion (intravenous route of insertion, subcutaneous route of insertion, intraosseous route of insertion) By Application (drug administration, fluid & nutrition administration, blood transfusion, diagnostics & testing) By End User (hospitals, clinics & ambulatory care centers, other end users).
Key Players:
Key market players, such Beckton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical (US), Terumo Corporation (Japan), and B Braun SE (Germany), Medtronic (Ireland), Vygon (France), Amecath (Egypt), AngioDynamics (US), Medical Components, Inc. (US), and Nipro (Japan), Merit Medical Systems (US), Health Line International Corporation (US), Medi-Tech Devices Pvt. Ltd. (India), Cook (US), and Argon Medical Devices (US), Access Vascular, Inc. (US), PakuMedmedical Products GmbH (Germany), Guangdong Baihe Medical Technology Co., Ltd. (China), Shanghai Puyi Medical Instruments Co., Ltd. (China), Newtech Medical Devices Pvt. Ltd. (India), DeltaMed (Italy), Kimal (UK), PolyMedicure (India), and PFM Medical GmbH (Germany)
Becton Dickinson and Company (US)
Becton Dickinson, a key player in the vascular access devices market, is renowned for its robust geographic presence and extensive product portfolio that includes central and peripheral venous access catheters. The company's acquisition of C.R. Bard for USD 24 billion significantly enhanced its product portfolio and market share. BD's strong global distribution network supports market stability by mitigating demand fluctuations across various geographies.
Teleflex Incorporated (US)
Teleflex boasts a rich history and extensive experience in the vascular access devices sector. The company markets its products under the Arrow brand and continues to innovate by launching new products, such as the Arrow Pressure Injectable Midline Catheter. These strategic launches have strengthened Teleflex's market position by addressing clinician needs and enhancing patient safety. Teleflex's expansion into regions like Europe and Africa has further solidified its market position.
ICU Medical (US)
ICU Medical's competitive edge lies in its comprehensive product portfolio, featuring central venous catheters, needle-free connectors, and more. The company's 2022 acquisition of Smiths Medical broadened its capabilities in infusion therapy applications, thereby enhancing its global reach and strengthening its market presence. ICU Medical emphasizes high-quality products that meet rigorous regulatory standards, alongside offering training and support to healthcare professionals.
A vascular access device (VAD) is a medical instrument inserted into a vein or artery to provide direct access to the bloodstream for delivering medications, fluids, or nutrients, as well as for drawing blood. Commonly used in long-term treatments like chemotherapy or dialysis, VADs are classified as central or peripheral depending on the site and duration of use. These devices are typically placed in the arm, chest, or leg and can remain in place for extended periods to support ongoing medical care.
The vascular access devices market is expected to grow from USD 5,991.2 million in 2024 to USD 9,057.2 million by 2030, at a CAGR of 7.1%. This growth is primarily driven by increased investment from key industry players and a rising prevalence of conditions that require vascular access. However, a shortage of skilled healthcare professionals may pose a challenge to market expansion.
The 360 Quadrant maps the Vascular Access Devices market companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Vascular Access Devices market quadrant. The top criteria for product footprint evaluation included Type (central venous access devices, peripheral vascular access devices, accessories, intraosseous vascular access devices), By Route of Insertion (intravenous route of insertion, subcutaneous route of insertion, intraosseous route of insertion) By Application (drug administration, fluid & nutrition administration, blood transfusion, diagnostics & testing) By End User (hospitals, clinics & ambulatory care centers, other end users).
Key Players:
Key market players, such Beckton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical (US), Terumo Corporation (Japan), and B Braun SE (Germany), Medtronic (Ireland), Vygon (France), Amecath (Egypt), AngioDynamics (US), Medical Components, Inc. (US), and Nipro (Japan), Merit Medical Systems (US), Health Line International Corporation (US), Medi-Tech Devices Pvt. Ltd. (India), Cook (US), and Argon Medical Devices (US), Access Vascular, Inc. (US), PakuMedmedical Products GmbH (Germany), Guangdong Baihe Medical Technology Co., Ltd. (China), Shanghai Puyi Medical Instruments Co., Ltd. (China), Newtech Medical Devices Pvt. Ltd. (India), DeltaMed (Italy), Kimal (UK), PolyMedicure (India), and PFM Medical GmbH (Germany)
Becton Dickinson and Company (US)
Becton Dickinson, a key player in the vascular access devices market, is renowned for its robust geographic presence and extensive product portfolio that includes central and peripheral venous access catheters. The company's acquisition of C.R. Bard for USD 24 billion significantly enhanced its product portfolio and market share. BD's strong global distribution network supports market stability by mitigating demand fluctuations across various geographies.
Teleflex Incorporated (US)
Teleflex boasts a rich history and extensive experience in the vascular access devices sector. The company markets its products under the Arrow brand and continues to innovate by launching new products, such as the Arrow Pressure Injectable Midline Catheter. These strategic launches have strengthened Teleflex's market position by addressing clinician needs and enhancing patient safety. Teleflex's expansion into regions like Europe and Africa has further solidified its market position.
ICU Medical (US)
ICU Medical's competitive edge lies in its comprehensive product portfolio, featuring central venous catheters, needle-free connectors, and more. The company's 2022 acquisition of Smiths Medical broadened its capabilities in infusion therapy applications, thereby enhancing its global reach and strengthening its market presence. ICU Medical emphasizes high-quality products that meet rigorous regulatory standards, alongside offering training and support to healthcare professionals.
1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 INCLUSIONS & EXCLUSIONS
1.3 STAKEHOLDERS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 Growing prevalence of lifestyle diseases
3.2.1.2 Increasing popularity of chemotherapy procedures among cancer patients
3.2.1.3 Rising use of vascular access devices among pediatric patients
3.2.2 RESTRAINTS
3.2.2.1 High cost of installation and maintenance of vascular access devices
3.2.2.2 Rising product recalls and failures
3.2.3 OPPORTUNITIES
3.2.3.1 Technological advancements
3.2.3.2 Increasing number of hospitals and expanding patient pool
3.2.4 CHALLENGES
3.2.4.1 Shortage of skilled healthcare professionals
3.2.4.2 Risks associated with use of vascular access devices
3.3 TECHNOLOGY ANALYSIS
3.3.1 KEY TECHNOLOGIES
3.3.1.1 Imaging and navigation technologies
3.3.1.2 Catheter securement and stabilization technologies
3.3.2 COMPLEMENTARY TECHNOLOGIES
3.3.2.1 AI and ML
3.3.3 ADJACENT TECHNOLOGIES
3.3.3.1 Infection control technologies
3.4 INDUSTRY TRENDS
3.4.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
3.4.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS
3.5 VALUE CHAIN ANALYSIS
3.6 ECOSYSTEM ANALYSIS
3.6.1 ROLE IN ECOSYSTEM
3.7 SUPPLY CHAIN ANALYSIS
3.8 PORTER’S FIVE FORCES ANALYSIS
3.8.1 THREAT OF NEW ENTRANTS
3.8.2 THREAT OF SUBSTITUTES
3.8.3 BARGAINING POWER OF BUYERS
3.8.4 BARGAINING POWER OF SUPPLIERS
3.8.5 INTENSITY OF COMPETITIVE RIVALRY
3.9 PATENT ANALYSIS
3.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
3.10 KEY CONFERENCES & EVENTS, 2025–2026
3.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
3.12 IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET
4 COMPETITIVE LANDSCAPE
4.1 INTRODUCTION
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
4.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
4.3 REVENUE ANALYSIS, 2019–2023
4.4 MARKET SHARE ANALYSIS, 2023
4.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
4.5.1 STARS
4.5.2 EMERGING LEADERS
4.5.3 PERVASIVE PLAYERS
4.5.4 PARTICIPANTS
4.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
4.5.5.1 Company footprint
4.5.5.2 Region footprint
4.5.5.3 Type footprint
4.5.5.4 Route of insertion footprint
4.5.5.5 Application footprint
4.5.5.6 End-user footprint
4.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
4.6.1 PROGRESSIVE COMPANIES
4.6.2 RESPONSIVE COMPANIES
4.6.3 DYNAMIC COMPANIES
4.6.4 STARTING BLOCKS
4.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
4.6.5.1 Detailed list of key startup/SME players
4.6.5.2 Competitive benchmarking of key emerging players/startups
4.7 COMPANY VALUATION & FINANCIAL METRICS
4.7.1 FINANCIAL METRICS
4.7.2 COMPANY VALUATION
4.8 BRAND/PRODUCT COMPARISON
4.9 COMPETITIVE SCENARIO
4.9.1 PRODUCT LAUNCHES & APPROVALS
4.9.2 DEALS
4.9.3 OTHER DEVELOPMENTS
5 COMPANY PROFILES
5.1 KEY PLAYERS
5.1.1 BECTON, DICKINSON AND COMPANY
5.1.1.1 Business overview
5.1.1.2 Products offered
5.1.1.3 Recent developments
5.1.1.3.1 Deals
5.1.1.4 MnM view
5.1.1.4.1 Key strengths
5.1.1.4.2 Strategic choices
5.1.1.4.3 Weaknesses & competitive threats
5.1.2 TELEFLEX INCORPORATED
5.1.2.1 Business overview
5.1.2.2 Products offered
5.1.2.3 Recent developments
5.1.2.3.1 Product launches
5.1.2.3.2 Other developments
5.1.2.4 MnM view
5.1.2.4.1 Key strengths
5.1.2.4.2 Strategic choices
5.1.2.4.3 Weaknesses & competitive threats
5.1.3 ICU MEDICAL
5.1.3.1 Business overview
5.1.3.2 Products offered
5.1.3.3 Recent developments
5.1.3.3.1 Deals
5.1.3.4 MnM view
5.1.3.4.1 Key strengths
5.1.3.4.2 Strategic choices
5.1.3.4.3 Weaknesses & competitive threats
5.1.4 NIPRO
5.1.4.1 Business overview
5.1.4.2 Products offered
5.1.4.3 MnM view
5.1.4.3.1 Key strengths
5.1.4.3.2 Strategic choices
5.1.4.3.3 Weaknesses & competitive threats
5.1.5 ANGIODYNAMICS, INC.
5.1.5.1 Business overview
5.1.5.2 Products offered
5.1.5.3 Recent developments
5.1.5.3.1 Product approvals
5.1.5.3.2 Deals
5.1.5.4 MnM view
5.1.5.4.1 Key strengths
5.1.5.4.2 Strategic choices
5.1.5.4.3 Weaknesses & competitive threats
5.1.6 VYGON
5.1.6.1 Business overview
5.1.6.2 Products offered
5.1.7 TERUMO CORPORATION
5.1.7.1 Business overview
5.1.7.2 Products offered
5.1.8 MEDTRONIC PLC
5.1.8.1 Business overview
5.1.8.2 Products offered
5.1.9 COOK
5.1.9.1 Business overview
5.1.9.2 Products offered
5.1.10 B. BRAUN SE
5.1.10.1 Business overview
5.1.10.2 Products offered
5.1.10.3 Recent developments
5.1.10.3.1 Product launches & approvals
5.1.10.3.2 Deals
5.1.11 MERIT MEDICAL SYSTEMS, INC.
5.1.11.1 Business overview
5.1.11.2 Products offered
5.1.11.3 Recent developments
5.1.11.3.1 Deals
5.1.12 AMECATH
5.1.12.1 Business overview
5.1.12.2 Products offered
5.1.13 MEDICAL COMPONENTS, INC.
5.1.13.1 Business overview
5.1.13.2 Products offered
5.1.14 HEALTHLINE MEDICAL PRODUCTS
5.1.14.1 Business overview
5.1.14.2 Products offered
5.1.15 ACCESS VASCULAR, INC.
5.1.15.1 Business overview
5.1.15.2 Products offered
5.2 OTHER PLAYERS
5.2.1 ARGON MEDICAL DEVICES
5.2.2 PAKUMEDMEDICAL PRODUCTS GMBH
5.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
5.2.4 PFM MEDICAL GMBH
5.2.5 MEDI-TECH DEVICES PVT. LTD.
5.2.6 KIMAL
5.2.7 POLYMEDICURE
5.2.8 DELTAMED
5.2.9 NEWTECH MEDICAL DEVICES PVT. LTD.
5.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.
6 APPENDIX
6.1 RESEARCH METHODOLOGY
6.1.1 RESEARCH DATA
6.1.1.1 Secondary data
6.1.1.2 Primary data
6.1.2 RESEARCH LIMITATIONS
6.1.3 RISK ANALYSIS
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY
6.3 AUTHOR DETAILS
1.1 MARKET DEFINITION
1.2 INCLUSIONS & EXCLUSIONS
1.3 STAKEHOLDERS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 Growing prevalence of lifestyle diseases
3.2.1.2 Increasing popularity of chemotherapy procedures among cancer patients
3.2.1.3 Rising use of vascular access devices among pediatric patients
3.2.2 RESTRAINTS
3.2.2.1 High cost of installation and maintenance of vascular access devices
3.2.2.2 Rising product recalls and failures
3.2.3 OPPORTUNITIES
3.2.3.1 Technological advancements
3.2.3.2 Increasing number of hospitals and expanding patient pool
3.2.4 CHALLENGES
3.2.4.1 Shortage of skilled healthcare professionals
3.2.4.2 Risks associated with use of vascular access devices
3.3 TECHNOLOGY ANALYSIS
3.3.1 KEY TECHNOLOGIES
3.3.1.1 Imaging and navigation technologies
3.3.1.2 Catheter securement and stabilization technologies
3.3.2 COMPLEMENTARY TECHNOLOGIES
3.3.2.1 AI and ML
3.3.3 ADJACENT TECHNOLOGIES
3.3.3.1 Infection control technologies
3.4 INDUSTRY TRENDS
3.4.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
3.4.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS
3.5 VALUE CHAIN ANALYSIS
3.6 ECOSYSTEM ANALYSIS
3.6.1 ROLE IN ECOSYSTEM
3.7 SUPPLY CHAIN ANALYSIS
3.8 PORTER’S FIVE FORCES ANALYSIS
3.8.1 THREAT OF NEW ENTRANTS
3.8.2 THREAT OF SUBSTITUTES
3.8.3 BARGAINING POWER OF BUYERS
3.8.4 BARGAINING POWER OF SUPPLIERS
3.8.5 INTENSITY OF COMPETITIVE RIVALRY
3.9 PATENT ANALYSIS
3.9.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
3.10 KEY CONFERENCES & EVENTS, 2025–2026
3.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
3.12 IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET
4 COMPETITIVE LANDSCAPE
4.1 INTRODUCTION
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
4.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
4.3 REVENUE ANALYSIS, 2019–2023
4.4 MARKET SHARE ANALYSIS, 2023
4.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
4.5.1 STARS
4.5.2 EMERGING LEADERS
4.5.3 PERVASIVE PLAYERS
4.5.4 PARTICIPANTS
4.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
4.5.5.1 Company footprint
4.5.5.2 Region footprint
4.5.5.3 Type footprint
4.5.5.4 Route of insertion footprint
4.5.5.5 Application footprint
4.5.5.6 End-user footprint
4.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
4.6.1 PROGRESSIVE COMPANIES
4.6.2 RESPONSIVE COMPANIES
4.6.3 DYNAMIC COMPANIES
4.6.4 STARTING BLOCKS
4.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
4.6.5.1 Detailed list of key startup/SME players
4.6.5.2 Competitive benchmarking of key emerging players/startups
4.7 COMPANY VALUATION & FINANCIAL METRICS
4.7.1 FINANCIAL METRICS
4.7.2 COMPANY VALUATION
4.8 BRAND/PRODUCT COMPARISON
4.9 COMPETITIVE SCENARIO
4.9.1 PRODUCT LAUNCHES & APPROVALS
4.9.2 DEALS
4.9.3 OTHER DEVELOPMENTS
5 COMPANY PROFILES
5.1 KEY PLAYERS
5.1.1 BECTON, DICKINSON AND COMPANY
5.1.1.1 Business overview
5.1.1.2 Products offered
5.1.1.3 Recent developments
5.1.1.3.1 Deals
5.1.1.4 MnM view
5.1.1.4.1 Key strengths
5.1.1.4.2 Strategic choices
5.1.1.4.3 Weaknesses & competitive threats
5.1.2 TELEFLEX INCORPORATED
5.1.2.1 Business overview
5.1.2.2 Products offered
5.1.2.3 Recent developments
5.1.2.3.1 Product launches
5.1.2.3.2 Other developments
5.1.2.4 MnM view
5.1.2.4.1 Key strengths
5.1.2.4.2 Strategic choices
5.1.2.4.3 Weaknesses & competitive threats
5.1.3 ICU MEDICAL
5.1.3.1 Business overview
5.1.3.2 Products offered
5.1.3.3 Recent developments
5.1.3.3.1 Deals
5.1.3.4 MnM view
5.1.3.4.1 Key strengths
5.1.3.4.2 Strategic choices
5.1.3.4.3 Weaknesses & competitive threats
5.1.4 NIPRO
5.1.4.1 Business overview
5.1.4.2 Products offered
5.1.4.3 MnM view
5.1.4.3.1 Key strengths
5.1.4.3.2 Strategic choices
5.1.4.3.3 Weaknesses & competitive threats
5.1.5 ANGIODYNAMICS, INC.
5.1.5.1 Business overview
5.1.5.2 Products offered
5.1.5.3 Recent developments
5.1.5.3.1 Product approvals
5.1.5.3.2 Deals
5.1.5.4 MnM view
5.1.5.4.1 Key strengths
5.1.5.4.2 Strategic choices
5.1.5.4.3 Weaknesses & competitive threats
5.1.6 VYGON
5.1.6.1 Business overview
5.1.6.2 Products offered
5.1.7 TERUMO CORPORATION
5.1.7.1 Business overview
5.1.7.2 Products offered
5.1.8 MEDTRONIC PLC
5.1.8.1 Business overview
5.1.8.2 Products offered
5.1.9 COOK
5.1.9.1 Business overview
5.1.9.2 Products offered
5.1.10 B. BRAUN SE
5.1.10.1 Business overview
5.1.10.2 Products offered
5.1.10.3 Recent developments
5.1.10.3.1 Product launches & approvals
5.1.10.3.2 Deals
5.1.11 MERIT MEDICAL SYSTEMS, INC.
5.1.11.1 Business overview
5.1.11.2 Products offered
5.1.11.3 Recent developments
5.1.11.3.1 Deals
5.1.12 AMECATH
5.1.12.1 Business overview
5.1.12.2 Products offered
5.1.13 MEDICAL COMPONENTS, INC.
5.1.13.1 Business overview
5.1.13.2 Products offered
5.1.14 HEALTHLINE MEDICAL PRODUCTS
5.1.14.1 Business overview
5.1.14.2 Products offered
5.1.15 ACCESS VASCULAR, INC.
5.1.15.1 Business overview
5.1.15.2 Products offered
5.2 OTHER PLAYERS
5.2.1 ARGON MEDICAL DEVICES
5.2.2 PAKUMEDMEDICAL PRODUCTS GMBH
5.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
5.2.4 PFM MEDICAL GMBH
5.2.5 MEDI-TECH DEVICES PVT. LTD.
5.2.6 KIMAL
5.2.7 POLYMEDICURE
5.2.8 DELTAMED
5.2.9 NEWTECH MEDICAL DEVICES PVT. LTD.
5.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.
6 APPENDIX
6.1 RESEARCH METHODOLOGY
6.1.1 RESEARCH DATA
6.1.1.1 Secondary data
6.1.1.2 Primary data
6.1.2 RESEARCH LIMITATIONS
6.1.3 RISK ANALYSIS
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY
6.3 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM
TABLE 2 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 3 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
TABLE 4 VASCULAR ACCESS DEVICES MARKET: DEGREE OF COMPETITION
TABLE 5 VASCULAR ACCESS DEVICES MARKET: REGION FOOTPRINT
TABLE 6 VASCULAR ACCESS DEVICES MARKET: TYPE FOOTPRINT
TABLE 7 VASCULAR ACCESS DEVICES MARKET: ROUTE OF INSERTION FOOTPRINT
TABLE 8 VASCULAR ACCESS DEVICES MARKET: APPLICATION FOOTPRINT
TABLE 9 VASCULAR ACCESS DEVICES MARKET: END-USER FOOTPRINT
TABLE 10 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 11 VASCULAR ACCESS DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 12 VASCULAR ACCESS DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 13 VASCULAR ACCESS DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025
TABLE 14 VASCULAR ACCESS DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 15 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 16 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 17 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–JANUARY 2025
TABLE 18 TELEFLEX INCORPORATED: COMPANY OVERVIEW
TABLE 19 TELEFLEX INCORPORATED: PRODUCTS OFFERED
TABLE 20 TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
TABLE 21 TELEFLEX INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 22 ICU MEDICAL: COMPANY OVERVIEW
TABLE 23 ICU MEDICAL: PRODUCTS OFFERED
TABLE 24 ICU MEDICAL: DEALS, JANUARY 2021–JANUARY 2025
TABLE 25 NIPRO: COMPANY OVERVIEW
TABLE 26 NIPRO: PRODUCTS OFFERED
TABLE 27 ANGIODYNAMICS, INC.: COMPANY OVERVIEW
TABLE 28 ANGIODYNAMICS, INC.: PRODUCTS OFFERED
TABLE 29 ANGIODYNAMICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 30 ANGIODYNAMICS, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 31 VYGON: COMPANY OVERVIEW
TABLE 32 VYGON: PRODUCTS OFFERED
TABLE 33 TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 34 TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 35 MEDTRONIC PLC: COMPANY OVERVIEW
TABLE 36 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 37 COOK: COMPANY OVERVIEW
TABLE 38 COOK: PRODUCTS OFFERED
TABLE 39 B. BRAUN SE: COMPANY OVERVIEW
TABLE 40 B. BRAUN SE: PRODUCTS OFFERED
TABLE 41 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 42 B. BRAUN SE: DEALS, JANUARY 2021–JANUARY 2025
TABLE 43 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 44 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
TABLE 45 MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 46 AMECATH: COMPANY OVERVIEW
TABLE 47 AMECATH: PRODUCTS OFFERED
TABLE 48 MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW
TABLE 49 MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED
TABLE 50 HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW
TABLE 51 HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED
TABLE 52 ACCESS VASCULAR, INC.: COMPANY OVERVIEW
TABLE 53 ACCESS VASCULAR, INC.: PRODUCTS OFFERED
TABLE 54 ARGON MEDICAL DEVICES: COMPANY OVERVIEW
TABLE 55 PAKUMEDMEDICAL PRODUCTS GMBH: COMPANY OVERVIEW
TABLE 56 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 57 PFM MEDICAL GMBH: COMPANY OVERVIEW
TABLE 58 MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW
TABLE 59 KIMAL: COMPANY OVERVIEW
TABLE 60 POLYMEDICURE: COMPANY OVERVIEW
TABLE 61 DELTAMED: COMPANY OVERVIEW
TABLE 62 NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW
TABLE 63 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
TABLE 64 VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS
TABLE 1 VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM
TABLE 2 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 3 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
TABLE 4 VASCULAR ACCESS DEVICES MARKET: DEGREE OF COMPETITION
TABLE 5 VASCULAR ACCESS DEVICES MARKET: REGION FOOTPRINT
TABLE 6 VASCULAR ACCESS DEVICES MARKET: TYPE FOOTPRINT
TABLE 7 VASCULAR ACCESS DEVICES MARKET: ROUTE OF INSERTION FOOTPRINT
TABLE 8 VASCULAR ACCESS DEVICES MARKET: APPLICATION FOOTPRINT
TABLE 9 VASCULAR ACCESS DEVICES MARKET: END-USER FOOTPRINT
TABLE 10 VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 11 VASCULAR ACCESS DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 12 VASCULAR ACCESS DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 13 VASCULAR ACCESS DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025
TABLE 14 VASCULAR ACCESS DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 15 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 16 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 17 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–JANUARY 2025
TABLE 18 TELEFLEX INCORPORATED: COMPANY OVERVIEW
TABLE 19 TELEFLEX INCORPORATED: PRODUCTS OFFERED
TABLE 20 TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025
TABLE 21 TELEFLEX INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025
TABLE 22 ICU MEDICAL: COMPANY OVERVIEW
TABLE 23 ICU MEDICAL: PRODUCTS OFFERED
TABLE 24 ICU MEDICAL: DEALS, JANUARY 2021–JANUARY 2025
TABLE 25 NIPRO: COMPANY OVERVIEW
TABLE 26 NIPRO: PRODUCTS OFFERED
TABLE 27 ANGIODYNAMICS, INC.: COMPANY OVERVIEW
TABLE 28 ANGIODYNAMICS, INC.: PRODUCTS OFFERED
TABLE 29 ANGIODYNAMICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 30 ANGIODYNAMICS, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 31 VYGON: COMPANY OVERVIEW
TABLE 32 VYGON: PRODUCTS OFFERED
TABLE 33 TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 34 TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 35 MEDTRONIC PLC: COMPANY OVERVIEW
TABLE 36 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 37 COOK: COMPANY OVERVIEW
TABLE 38 COOK: PRODUCTS OFFERED
TABLE 39 B. BRAUN SE: COMPANY OVERVIEW
TABLE 40 B. BRAUN SE: PRODUCTS OFFERED
TABLE 41 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025
TABLE 42 B. BRAUN SE: DEALS, JANUARY 2021–JANUARY 2025
TABLE 43 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 44 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
TABLE 45 MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021–JANUARY 2025
TABLE 46 AMECATH: COMPANY OVERVIEW
TABLE 47 AMECATH: PRODUCTS OFFERED
TABLE 48 MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW
TABLE 49 MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED
TABLE 50 HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW
TABLE 51 HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED
TABLE 52 ACCESS VASCULAR, INC.: COMPANY OVERVIEW
TABLE 53 ACCESS VASCULAR, INC.: PRODUCTS OFFERED
TABLE 54 ARGON MEDICAL DEVICES: COMPANY OVERVIEW
TABLE 55 PAKUMEDMEDICAL PRODUCTS GMBH: COMPANY OVERVIEW
TABLE 56 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 57 PFM MEDICAL GMBH: COMPANY OVERVIEW
TABLE 58 MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW
TABLE 59 KIMAL: COMPANY OVERVIEW
TABLE 60 POLYMEDICURE: COMPANY OVERVIEW
TABLE 61 DELTAMED: COMPANY OVERVIEW
TABLE 62 NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW
TABLE 63 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
TABLE 64 VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS
LIST OF FIGURES
FIGURE 1 CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 2 TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030
FIGURE 3 IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD
FIGURE 4 PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 5 PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 6 INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE FROM 2024 TO 2030
FIGURE 7 DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN APPLICATIONS SEGMENT
FIGURE 8 CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD
FIGURE 9 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 10 PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD
FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR VASCULAR ACCESS DEVICES
FIGURE 12 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13 VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 14 VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 15 VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 16 VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 17 NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–DECEMBER 2024)
FIGURE 18 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014?DECEMBER 2024)
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES (JANUARY 2014? DECEMBER 2024)
FIGURE 20 VASCULAR ACCESS DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 21 VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI
FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2019–2023)
FIGURE 23 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2023)
FIGURE 24 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 25 VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT
FIGURE 26 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 27 EV/EBITDA OF KEY VENDORS
FIGURE 28 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 29 VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 31 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
FIGURE 32 ICU MEDICAL: COMPANY SNAPSHOT
FIGURE 33 NIPRO: COMPANY SNAPSHOT
FIGURE 34 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
FIGURE 35 TERUMO CORPORATION: COMPANY SNAPSHOT
FIGURE 36 MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 37 B. BRAUN SE: COMPANY SNAPSHOT
FIGURE 38 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
FIGURE 39 VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN
FIGURE 40 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 41 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 1 CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 2 TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030
FIGURE 3 IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD
FIGURE 4 PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 5 PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 6 INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE FROM 2024 TO 2030
FIGURE 7 DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN APPLICATIONS SEGMENT
FIGURE 8 CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD
FIGURE 9 HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 10 PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD
FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR VASCULAR ACCESS DEVICES
FIGURE 12 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13 VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 14 VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 15 VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 16 VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 17 NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–DECEMBER 2024)
FIGURE 18 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014?DECEMBER 2024)
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES (JANUARY 2014? DECEMBER 2024)
FIGURE 20 VASCULAR ACCESS DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 21 VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI
FIGURE 22 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2019–2023)
FIGURE 23 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2023)
FIGURE 24 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 25 VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT
FIGURE 26 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 27 EV/EBITDA OF KEY VENDORS
FIGURE 28 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 29 VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 31 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
FIGURE 32 ICU MEDICAL: COMPANY SNAPSHOT
FIGURE 33 NIPRO: COMPANY SNAPSHOT
FIGURE 34 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
FIGURE 35 TERUMO CORPORATION: COMPANY SNAPSHOT
FIGURE 36 MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 37 B. BRAUN SE: COMPANY SNAPSHOT
FIGURE 38 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
FIGURE 39 VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN
FIGURE 40 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 41 VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
